Navigation Links
Blue Cross' Stop-Smoking Program Achieves All-Time High Quit Rate
Date:4/3/2008

Success due to implementation of best practices in stop smoking strategies

EAGAN, Minn., April 3, 2008 /PRNewswire/ -- Blue Cross and Blue Shield of Minnesota (Blue Cross) reports it achieved an all-time high, 12-month stop smoking rate of 35.5 percent in 2007; meaning at least one in three members who enrolled in Blue Cross' stop smoking program -- 1,714 individuals -- was still not smoking 12 months after starting the program. The new quit rate represents a twenty-one percent increase (six percentage points) over the 2006 rate of 29.3 percent. The 35.5 percent quit rate is also more than seven times higher than the overall national quit rate of less than 4.7 percent. The national quit rate includes all smokers who quit by any means in a year, including program participation, medications, or with no assistance.

Blue Cross' stop-smoking program consistently yields meaningful results both for program participants and their employers. "The success of this program comes from significant improvements we've made and from the Freedom to Breathe Act," said Dr. Marc Manley, vice president and medical director for population health at Blue Cross. "Now that smoking isn't allowed in restaurants and bars, it's a little easier for smokers to quit."

In May 2007 Blue Cross rolled-out its enhanced stop-smoking program where, in addition to the phone and web-based coaching, employers cover the cost of quit medications for their employees and their dependents who are 18 or older. The best opportunity for success is achieved when the comprehensive approach of tailored coaching linked to no-cost quit medications (for example the nicotine patch, gum, and lozenge) is combined with supportive environments in the community, at home and at the workplace. Blue Cross also offers workplace health improvement planning support to employers who wish to implement a tobacco-free worksite policy covering buildings and grounds.

"As we recognize 'Kick Butts Day' and the
'/>"/>

SOURCE Blue Cross and Blue Shield of Minnesota
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Breast cancer prevention practices vary across Canada
2. S.C. BlueCross Creates Corporate Planning Unit, Promotes Davis to Vice President
3. S.C. BlueCross to Integrate Care Management with Personal Health Record in Real Time
4. BlueCare(R) Family Plan, a HUSKY Health Plan from Anthem Blue Cross and Blue Shield in Connecticut, Raises Awareness, Funds and Diapers for New Haven Diaper Bank
5. Blue Cross Blue Shield of Michigan Corrects News Story about Drug Coverage Announcement
6. Independence Blue Cross Makes Music for Members Ears
7. Hundreds of RNs from Across U.S. and World to Join California Nurses Association/NNOC National Convention
8. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
9. Harvard Researchers Select S.C. BlueCross for National Honor
10. Highmark Blue Cross Blue Shield Introduces New Health Plan Comparison Tool for Consumers
11. Blue Cross and Blue Shield Initiatives Recognized for Increasing Patient Safety and Efficiency

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...k in the Journal of Neurosurgery: Pediatrics fin...cytic Astrocytoma, or JPA, tumors in the thalamus ...r Imaging, or DTI. The sensitivity of DTI imaging...es in the brain. This information can maximize th... avoiding damage to the fiber bundles that are dir...
(Date:12/4/2009)... Corp., a leading manufacturer of over-the-counter...enhance consumers’ quality of life, today an...can Podiatric Medical Association (APMA) Seal of A...iFeet®. , (PRWEB) De...urer of over-the-counter topical cream and first a...
(Date:12/4/2009)..., Dec. 4 , ,What: Humana...care, health benefits provider, is i...agames.com ), a senior-friendly dance pad, ... on Tues., Dec. 8 at 1 p.m. The fes...d open to the public, will feature Dancetown, ...
(Date:12/4/2009)...4 PLUS Diagnostics announced tod...hology services with the launch of a national hema...s the company,s expansion from a regional laborato...y offering diagnostic services across a full range...y and now hematology/oncology. ,, PLUS Diagnos...
(Date:12/4/2009)...PRNewswire/ -- The National Cancer Institute has a...Fred Hutchinson Cancer Research Center to become t...n Service Contact Center. ,, The move will crea...ripling the size of its current CIS workforce - on...hich is scheduled for March 15, 2010. The Seattle ...
Breaking Medicine News(10 mins):Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 2Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 3Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 4Health News:Humana Launches Dancetown on Tues., Dec. 8 in Kissimmee 2Health News:PLUS Diagnostics Launches Hematology/Oncology Diagnostic Services 2Health News:PLUS Diagnostics Launches Hematology/Oncology Diagnostic Services 3Health News:Hutchinson Center Wins $55.4 Million Contract to Become Sole Operator of the NCI Cancer Information Service 2
... Smokers who have an easier ...es that can foster success, according to a new stu... Institute on Drug Abuse. , ... according to a new study by a team of federal sci...
...linical pharmacy services can significantly reduce...ewhere in the health care system, according to a n...ois at Chicago. , For every dollar spent by hospi...on errors and other savings, says Glen Schumock, a...
...ing may help unravel how diseases form, , ...ne acting very differently in different tissues ma...w likely a person is to get a disease, a new repor...Such variation can lead to alternative splicing, a...
...y points to 16 states where Medicaid doesn,t fund ... News) -- Thousands of male infants aren,t being c...over the procedure through Medicaid, new research ... policy at the University of California, Los Angel...
...he use of radiation therapy to treat cancer inevit... the benefits of this treatment have been well est...ing complications as a result injury to normal tis.... , A research article to be published on Decemb...
...ing a favorite ritual might ease a friend or famil...lthDay News) -- If a family member or friend is in...r them up by bringing a bit of Christmas from home...ist Hospital in Houston, said in a hospital news r...
Other Medicine News:Health News:Studies on Smoking Genes and Transcriptional Control of Chronic Fatigue Syndrome Revealed in Molecular Medicine 2Health News:Genes Seem to Affect Tissues Differently 2Health News:Circumcision Rates Too Low 2Health News:What is the mechanism of the chronic radiation enteritis? 2Health News:Take the Holiday to the Hospital 2
(Date:12/3/2009)... Ted Karkus, Chairman an... www.quigleyco.com announced today that the Comp...ies to develop prescription pharmaceutical and OTC... interests to focus primarily on the OTC/Personal ...mited to its Cold-EEZE® and Kids-EEZE® b...
(Date:12/3/2009)...rk and SAN DIEGO, California, December 3 /PRNewswi...miR-122, a microRNA Important for,Hepatitis C Vira...titis C,Virus in the Bloodstream in Chimpanzees Ch..., - SPC3649 Demonstrates Efficacy With No Evi...vents in the Treated Animals - Signaling a Potenti...
(Date:12/3/2009)...re-FirstCall/ -- Cardium Therapeutics (NYSE Amex: ...diary, Tissue Repair Company, submitted a 510(k) p...d Drug Administration (FDA) seeking marketing clea...sed on positive data from the Company,s recently c...submission with the FDA covers Excellagen XL(TM) ...
Breaking Medicine Technology:Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 2Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 4Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 5Lure of Bottled Water May Not Be Health Driven 49525 1WellPoint to Hold Conference Call and Webcast to Discuss Second Quarter Results on July 29 2009 49523 1WellPoint to Hold Conference Call and Webcast to Discuss Second Quarter Results on July 29 2009 49523 2Make Nursing Homes More Like Home 3A Medicare 49521 1Make Nursing Homes More Like Home 3A Medicare 49521 2
...ive Insulin-Based Therapies, Market,Growth Will be...om Decision Resource...ne of the,world,s leading research and advisory fi...s that the most significant driver of growth in th...standard of care away from,regular human insulins ...
...09, SEATTLE, Aug. 12 Cell Therapeutics, Inc.,s,(...cine (SM) announced today,that planned enrollment ...rch and Treatment of Cancer (EORTC) randomized pha...ith newly diagnosed advanced or metastatic,soft ti...he primary,endpoint of the trial is progression-fr...
Other Medicine Technology:Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market 2Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma 2Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma 3Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma 4Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma 5Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma 6
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: